Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle
about
RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonistProduction of novel rapamycin analogs by precursor-directed biosynthesis.Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae.The biosynthetic gene cluster for the polyketide immunosuppressant rapamycinThe TOR pathway comes of ageProtein kinases and phosphatases in the control of cell fatePotential use of rapamycin in HIV infectionUpdates of mTOR inhibitorsmTOR inhibitors in advanced renal cell carcinomaThe mTOR signalling pathway in human cancerNext-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategyEverolimus-eluting stents in interventional cardiologyPrinciples of microbial alchemy: insights from the Streptomyces coelicolor genome sequenceInhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and BeyondDeveloping criteria for evaluation of geroprotectors as a key stage toward translation to the clinicNatural Products as Tools for Defining How Cellular Metabolism Influences Cellular Immune and Inflammatory Function during Chronic InfectionCancer wars: natural products strike backmTOR Signaling in Protein Translation Regulation: Implications in Cancer Genesis and Therapeutic InterventionsShedding new light on neurodegenerative diseases through the mammalian target of rapamycinCurrent and emerging strategies for the prevention of graft-versus-host diseaseA MultiSite Gateway Toolkit for Rapid Cloning of Vertebrate Expression Constructs with Diverse Research Applications.Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTORLarge FK506-Binding Proteins Shape the Pharmacology of RapamycinFrom Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials.Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding proteinMds3 regulates morphogenesis in Candida albicans through the TOR pathwayTechniques for studying protein trafficking and molecular motors in neuronsProfile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapymTOR inhibitors in cancer therapyMicro and nanoparticle drug delivery systems for preventing allotransplant rejectionmTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and agingmTOR: a potential therapeutic target in osteoarthritis?mTOR signaling in tumorigenesisCurrent development of mTOR inhibitors as anticancer agentsInTERTesting association between telomerase, mTOR and phytochemicalsThe Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and AgingRapalogs and mTOR inhibitors as anti-aging therapeuticsWhere is mTOR and what is it doing there?Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug actionRapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR
P2860
Q21132391-3EB9CF36-A342-4B26-BDCD-1F595C60901EQ24522424-32186E43-49A2-431A-B546-5E1F7B59872BQ24537557-AA2A4F9E-8A2B-4382-BFB3-7EC288B7B25EQ24561472-85AFC637-45FC-4F5E-A26B-474A1EC17160Q24568353-148B4283-43B9-4EBA-A4B0-9AD9146B767AQ24604987-808F6947-D8C1-498B-B248-D463C3B1C030Q24606795-843BE9F8-A7D5-4E55-B7C3-79AAD04D42A3Q24607170-6D94234D-4D4F-4C83-8FD4-5B24114315A7Q24612127-EDD407DF-F1FF-483A-B4BD-0A846A399337Q24627306-7F33A0EF-7917-40DF-BC02-4307C14CF0D5Q24628724-9C734416-3D5C-4EDC-9F32-B46005B3F159Q24630321-D106FDB2-BA2B-4575-9A2F-74CD27B1379DQ24792373-1B022035-8E6F-4ED4-AA24-52899B3CED3AQ26751462-D1CC4029-CA60-46A6-A7E7-CBC1FD33C6E9Q26766217-DCC9F3A9-4F6E-4FEB-ACAE-E56B267C2CD7Q26775036-79621154-B05B-4C75-A7D0-343B64D81841Q26850074-716E6238-8F4E-4CC2-8BC0-1CC0B6A61E19Q27007511-2654A0E9-1A9F-4109-9C2B-464339BF4F0FQ27015640-83ADB19D-0D3A-4B95-9A9F-96848901425AQ27016541-23ECEB3F-7089-42CB-8449-B758BB361062Q27334567-7C254FC1-1910-45C9-B6C8-38755A621FE8Q27647018-163F7D07-8714-4A25-AD8F-244C8B2005FFQ27676039-7BAF770B-B2EA-4467-9086-232E4C13B11EQ27687259-2E3A3D0F-0970-4696-B3E9-9CC84972C87DQ27934061-4060F05B-998A-479A-ABEB-414264A7C73FQ27940288-3E7F7D9D-EC1C-47F7-92FF-AC540F950530Q28069702-01C2A80A-6439-4A12-B39D-6E40C966A122Q28078328-F43E63E5-FA56-4CC1-A112-1B50595F8277Q28079129-49771D40-04DF-4E81-ABB2-172BB33C84B0Q28080720-4A628E4C-50B0-42F0-9155-16A71800369AQ28081442-4D9DC953-07FF-4B64-A6E9-89237EC83B8CQ28087019-DA05D37C-65D9-4754-957D-32AE546765ECQ28252695-893512F9-2795-4FCF-9559-92FA888D9DFDQ28255366-2BE046F1-5FD3-45F8-A647-181DA2C4299FQ28262993-23060E10-86E9-42C9-B917-0233AC28813AQ28276378-07A64709-4E6E-42E6-AB6D-92749F52C144Q28286510-A8586494-1112-4DAF-A6FA-069BA6B98383Q28305068-3BCB8047-1306-4123-9AAB-4D4C43BBB15CQ28343624-9BDB1147-52AC-4036-B0C2-06F5BC182D9BQ28361576-B291BF99-74C6-454C-9AEF-7978514ECF68
P2860
Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle
description
1975 nî lūn-bûn
@nan
1975 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Rapamycin (AY-22,989), a new a ...... lation of the active principle
@ast
Rapamycin (AY-22,989), a new a ...... lation of the active principle
@en
Rapamycin (AY-22,989), a new a ...... lation of the active principle
@nl
type
label
Rapamycin (AY-22,989), a new a ...... lation of the active principle
@ast
Rapamycin (AY-22,989), a new a ...... lation of the active principle
@en
Rapamycin (AY-22,989), a new a ...... lation of the active principle
@nl
prefLabel
Rapamycin (AY-22,989), a new a ...... lation of the active principle
@ast
Rapamycin (AY-22,989), a new a ...... lation of the active principle
@en
Rapamycin (AY-22,989), a new a ...... lation of the active principle
@nl
P2093
P3181
P1476
Rapamycin (AY-22,989), a new a ...... lation of the active principle
@en
P2093
P3181
P356
10.7164/ANTIBIOTICS.28.721
P407
P577
1975-10-01T00:00:00Z